Due to hemophilia A patients switching to newer treatments, Takeda Pharmaceuticals is discontinuing both Hemofil M and ...

BioLife Plasma Services has invested $4 million to expand its Hoover, Ala. testing lab by 1,750 square feet and acquire equipment to recycle biohazardous waste more efficiently.

Although the regulatory landscape for advanced therapy medicinal products (ATMPs) is rapidly evolving, varying regulatory ...

David Shih, Ahmad Kamal, Red Concepción , Scott Keiji Takeda, Michael Hisamoto, and Earl T. Kim. Photo by Emma Zordan Sumo is ...

Trio files multiple patent infringement lawsuits to protect blockbuster prostate cancer drug | Latest suits target Hetero and ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...

Encouraging preclinical data supporting the use of DNase-based technology to target NETosis and address difficult to treat cancersStrategic focus ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”, the “Company” or “we”) ...

1, Minjee Lee, 5. 2, Rio Takeda, 4. 3, Lauren Coughlin, 3. 4, 14 tied with 2. 1 (tie), Saki Baba, Jaravee Boonchant, In Gee Chun, Kumkang Park, Julia Lopez Ramirez, Miranda Wang, Fiona Xu and Liqi ...

Duska noted that the PD-L1 inhibitor pembrolizumab has shown efficacy in the treatment of recurrent or metastatic cervical ...